0.00
100.00%
-0.2071
Handel nachbörslich:
.13
0.13
+
Renalytix Plc Adr Aktie (RNLX) Neueste Nachrichten
Renalytix restructures option plan for top management - Investing.com
Renalytix executives engage in share transactions - Investing.com
Stock Market Recap: Renalytix Plc ADR (RNLX) Concludes at 0.21, a 5.66 Surge/Decline - The Dwinnex
Commencement of trading on OTCQB in the United States - StockTitan
What was Renalytix Plc ADR (RNLX)’s performance in the last session? - US Post News
Renalytix Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Ratios in Focus: Analyzing Renalytix Plc ADR (RNLX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Renalytix AI stock hits 52-week low at $0.22 amid market challenges - Investing.com
Renalytix Plc ADR (RNLX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
There is no way Renalytix Plc ADR (RNLX) can keep these numbers up - SETE News
How analysts predict Renalytix Plc ADR (RNLX) will perform this quarter? - US Post News
Renalytix Plc ADR (RNLX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Investor’s Delight: Renalytix Plc ADR (RNLX) Closes Strong at 0.31, Up 7.31 - The Dwinnex
Renalytix Plc ADR (RNLX) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Analyzing RNLX’s price-to-book ratio for the last quarter - US Post News
Renalytix Plc ADR (RNLX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Closing Figures: Renalytix Plc ADR (RNLX)’s Negative Finish at 0.31, Down -23.14 - The Dwinnex
Form 8.5 (EPT/RI)-Renalytix Plc - GlobeNewswire Inc.
Investing in Renalytix Plc ADR (RNLX) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Examining Renalytix Plc ADR (RNLX) more closely is necessary - US Post News
Renalytix AI shares hold buy rating from HC Wainwright - Investing.com
Renalytix Partners with Steno for Kidney Care in Europe - Investing.com
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - Yahoo Finance UK
Renalytix faces delisting from Nasdaq over noncompliance - Investing.com
Medicare sets $950 price for Renalytix kidney test - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Investing.com South Africa
Fragrant Prosperity slumps as reverse takeover falls through - Proactive Investors USA
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):